Johnson and Arnvig Lab | of noisy ' leaders in Mycobacterium tuberculosis heterogeneity

A 2027 Crick-University College London Joint PhD project with Eachan Johnson (Crick) and Kristine Arnvig (UCL).

Please note:

to apply to this project, candidates must be eligible for home tuition fee status.

The human pathogen Mycobacterium tuberculosis (Mtb) is renowned for its pronounced cell-to-cell variability within populations of genetically identical cells[1]. This “phenotypic heterogeneity” is based on stochastic gene expression, and the result is a bacterial population with a selective advantage, increasing the likelihood that individual members of the population survive when exposed to a wide range of stress conditions (bet hedging). This phenomenon is a prerequisite for the generation of phenotypically drug-tolerant cells which may be responsible for the requisite six-month duration of tuberculosis chemotherapy[2].

Therefore, understanding the molecular mechanisms behind cell-to-cell variability may reveal new intervention points and strategies.
While previous studies have focussed on the role of promoter-driven noise and transcriptional fluctuations[3] the contributions of post-transcriptional noise from 5' leaders remain poorly understood. Premature termination, riboswitches, and idiosyncratic short, translated leaders (uORFs) are emerging as important but previously underappreciated features of Mtb post-transcriptional regulation.
The Arnvig lab has a strong track-record in functional characterisation in Mtb of riboswitches, metabolite-sensing RNA leaders that control downstream gene expression often through ligand-dependent changes in premature transcription termination[4]. Her lab has also identified hundreds of uncharacterised, regulatory 5' leaders using termseq[5]. These leaders, some potentially new riboswitches, provide a rich resource for further studies on post-transcriptional noise.
Beyond the transcriptional stochasticity (noise) in Mtb characterised by the Johnson lab, this project will investigate the extent of stochasticity associated with selected 5' leaders and the role they play in population survival of lethal antibiotic doses in Mycobacterium smegmatis and Mtb. We will use dual fluorescence reporter system established in the Johnson lab coupled with flow cytometry and next-generation sequencing (FACS-seq) to establish distributions of expression levels driven by multiplexed genomic sequences, thus yielding the bacterium-to-bacterium variability of expression influenced by many different 5' leaders in parallel.
Noisy leaders will be further characterised by our newly devised strategy involving over expressing of the leader regions of interest in Mycobacterium smegmatis and Mtb. This will promote ligand sequestration and trigger changes in regulatory and metabolic pathways. We will subsequently apply multi-omics (RNA-seq, proteomics and metabolomics) and integrate their outputs using systems biology approaches to identify dysregulated metabolic pathways and potential ligands, which will be validated in vitro using inline probing and SHAPE-seq.

The identification and characterisation of noisy leaders and how they respond to their cognate ligands represent new points of potential intervention in the fight against tuberculosis and wider antimicrobial resistance.

This project is aimed at candidates with a background in biochemistry, molecular biology and computational biology or biological engineering. The student will have an interest in fundamental mechanisms of pathogen biology including transcriptional and post-transcriptional regulation of gene expression, broader RNA biology and…